Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2008

01.06.2008

Systemic Lupus Erythematosus Involving the Nervous System: Presentation, Pathogenesis, and Management

verfasst von: Julia J. Rhiannon

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Neuropsychiatric syndromes in systemic lupus erythematosus (SLE) have a wide range of severity and phenotype and are fairly common. Presentations are seen involving both central and peripheral nervous systems. Pathogenic mechanisms are thought to include vascular occlusion and hemorrhage, antineuronal antibodies, cytokine effects, choroid plexus dysfunction, neuroendocrine–immune effects, and direct central nervous system (CNS) tissue injury. Work-up includes serum, cerebrospinal fluid (CSF), and imaging studies. Treatment is based on severity and phenotype and includes steroids, anticoagulants, antidepressants, and cytotoxic approaches. Much remains to be done in terms of further elucidation of pathologic processes, correlation of these mechanisms with specific phenotypes, and management of the most severe presentations of neuropsychiatric lupus erythematosus.
Literatur
1.
Zurück zum Zitat Stojanovich L et al (2007) Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 6:421–426PubMedCrossRef Stojanovich L et al (2007) Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 6:421–426PubMedCrossRef
2.
Zurück zum Zitat West S (2006) Systemic lupus erythematosus and the nervous system. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott, Williams and Wilkins, Philadelphia, p 707–736 West S (2006) Systemic lupus erythematosus and the nervous system. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematosus, 6th edn. Lippincott, Williams and Wilkins, Philadelphia, p 707–736
3.
Zurück zum Zitat Ahrens D et al (1996) Expression of matrix metalloproteinase 9 (96kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39(9):1576–1587PubMedCrossRef Ahrens D et al (1996) Expression of matrix metalloproteinase 9 (96kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39(9):1576–1587PubMedCrossRef
4.
Zurück zum Zitat Matsukawa Y et al (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3(1):31–35PubMedCrossRef Matsukawa Y et al (1994) Suicide in patients with systemic lupus erythematosus: a clinical analysis of seven suicidal patients. Lupus 3(1):31–35PubMedCrossRef
5.
Zurück zum Zitat Karassa F et al (2003) Suicide attempts in patients with systemic lupus erythematosus. Ann Rheum Dis 62(1):58–60PubMedCrossRef Karassa F et al (2003) Suicide attempts in patients with systemic lupus erythematosus. Ann Rheum Dis 62(1):58–60PubMedCrossRef
6.
Zurück zum Zitat Sullivan-Marx E et al (2001) Delirium. In: Maddox G (ed) The encyclopedia of aging, 3rd edn. Springer, New York, NY Sullivan-Marx E et al (2001) Delirium. In: Maddox G (ed) The encyclopedia of aging, 3rd edn. Springer, New York, NY
7.
Zurück zum Zitat Jennekens F et al (2002) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 41(6):605–618PubMedCrossRef Jennekens F et al (2002) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology 41(6):605–618PubMedCrossRef
8.
Zurück zum Zitat Pompei P et al (1994) Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 42(8):809–815PubMed Pompei P et al (1994) Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 42(8):809–815PubMed
9.
Zurück zum Zitat Kotzin BL, Kozora E (2001) Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med 7(11):1175–1176PubMedCrossRef Kotzin BL, Kozora E (2001) Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med 7(11):1175–1176PubMedCrossRef
10.
Zurück zum Zitat Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci 103(52):19854–19859PubMedCrossRef Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci 103(52):19854–19859PubMedCrossRef
11.
Zurück zum Zitat Wekking E et al (1991) Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom 55(2–4):126–131PubMedCrossRef Wekking E et al (1991) Cognitive and emotional disturbances in systemic lupus erythematosus. Psychother Psychosom 55(2–4):126–131PubMedCrossRef
12.
Zurück zum Zitat Ginsburg K et al (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35(7):776–782PubMedCrossRef Ginsburg K et al (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35(7):776–782PubMedCrossRef
13.
Zurück zum Zitat Kiss E, Shoenfeld Y (2007) Are anti-ribosomal p protein antibodies relevant in systemic lupus erythematosus? Clin Rev Allergy Immunol 32(1):37–46PubMed Kiss E, Shoenfeld Y (2007) Are anti-ribosomal p protein antibodies relevant in systemic lupus erythematosus? Clin Rev Allergy Immunol 32(1):37–46PubMed
14.
Zurück zum Zitat Shoenfeld Y et al (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28(2–3):165–169PubMedCrossRef Shoenfeld Y et al (2007) To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J Autoimmun 28(2–3):165–169PubMedCrossRef
15.
Zurück zum Zitat Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6(3):119–125PubMedCrossRef Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6(3):119–125PubMedCrossRef
16.
Zurück zum Zitat Sun KH et al (2005) Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-α and iNOS in activated RAW macrophage cell line. J Autoimmun 24:135–143PubMedCrossRef Sun KH et al (2005) Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-α and iNOS in activated RAW macrophage cell line. J Autoimmun 24:135–143PubMedCrossRef
17.
Zurück zum Zitat Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60PubMedCrossRef Strous RD, Shoenfeld Y (2006) To smell the immune system: olfaction, autoimmunity and brain involvement. Autoimmun Rev 6:54–60PubMedCrossRef
18.
Zurück zum Zitat Muscal E, Myones B (2007) The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6(4):215–217PubMedCrossRef Muscal E, Myones B (2007) The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 6(4):215–217PubMedCrossRef
19.
Zurück zum Zitat Cavazzana I et al (2007) Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 28(2–3):160–164PubMedCrossRef Cavazzana I et al (2007) Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process? J Autoimmun 28(2–3):160–164PubMedCrossRef
20.
Zurück zum Zitat Kozora E et al (2001) Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J Int Neuropsychol Soc 7(6):745–754PubMedCrossRef Kozora E et al (2001) Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J Int Neuropsychol Soc 7(6):745–754PubMedCrossRef
21.
Zurück zum Zitat Hanly J et al (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40(8):1542–1543PubMedCrossRef Hanly J et al (1997) Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 40(8):1542–1543PubMedCrossRef
22.
Zurück zum Zitat Loukkola J et al (2003) Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol 25(1):145–151PubMedCrossRef Loukkola J et al (2003) Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol 25(1):145–151PubMedCrossRef
23.
Zurück zum Zitat Rao S (2004) Cognitive function in patients with multiple sclerosis: impairment and treatment. Int J M S Care 6(1):9–22 Rao S (2004) Cognitive function in patients with multiple sclerosis: impairment and treatment. Int J M S Care 6(1):9–22
24.
Zurück zum Zitat Ishikura R et al (2001) Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol 20(6):394–400PubMedCrossRef Ishikura R et al (2001) Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol 20(6):394–400PubMedCrossRef
25.
Zurück zum Zitat Denburg J et al (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37(3):464–467PubMed Denburg J et al (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37(3):464–467PubMed
26.
Zurück zum Zitat Fragoso-Loyo H et al (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56(4):1242–1250PubMedCrossRef Fragoso-Loyo H et al (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56(4):1242–1250PubMedCrossRef
27.
Zurück zum Zitat Stoppe G et al (1990) Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 40(2):304–308PubMed Stoppe G et al (1990) Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology 40(2):304–308PubMed
28.
Zurück zum Zitat Weiner S et al (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377–385PubMedCrossRef Weiner S et al (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59(5):377–385PubMedCrossRef
29.
Zurück zum Zitat Watreloo K et al (2002) Neurospychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology 41(4):411–415CrossRef Watreloo K et al (2002) Neurospychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology 41(4):411–415CrossRef
30.
Zurück zum Zitat Carlomagno S et al (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247(4):273–279PubMedCrossRef Carlomagno S et al (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247(4):273–279PubMedCrossRef
31.
Zurück zum Zitat Carbotte R et al (1995) Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatology 22:863–867 Carbotte R et al (1995) Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatology 22:863–867
32.
Zurück zum Zitat Denburg S et al (1997) Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatology 24:998–1003 Denburg S et al (1997) Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatology 24:998–1003
33.
Zurück zum Zitat Gonzales-Crespo M et al (1995) Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatology 34(11):1055–1060CrossRef Gonzales-Crespo M et al (1995) Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatology 34(11):1055–1060CrossRef
34.
Zurück zum Zitat Monastero R et al (2001) Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. Neurol Sci 184:33–39CrossRef Monastero R et al (2001) Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. Neurol Sci 184:33–39CrossRef
35.
Zurück zum Zitat Denburg S et al (1987) Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9(4):323–339PubMedCrossRef Denburg S et al (1987) Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9(4):323–339PubMedCrossRef
36.
Zurück zum Zitat Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28(2–3):69–75PubMedCrossRef Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28(2–3):69–75PubMedCrossRef
37.
Zurück zum Zitat Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmun 28(2–3):62–68PubMedCrossRef Blank M, Shoenfeld Y (2007) B cell targeted therapy in autoimmunity. J Autoimmun 28(2–3):62–68PubMedCrossRef
38.
Zurück zum Zitat Holvast B, Huckriede A, Kallenberg CG, Bijl M (2007) Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6(5):300–305PubMedCrossRef Holvast B, Huckriede A, Kallenberg CG, Bijl M (2007) Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6(5):300–305PubMedCrossRef
39.
Zurück zum Zitat Elkayam O, Ablin J, Caspi D (2007) Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 6(5):312–314PubMedCrossRef Elkayam O, Ablin J, Caspi D (2007) Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 6(5):312–314PubMedCrossRef
40.
Zurück zum Zitat Koike T, Bohgaki M, Amengual O, Atsumi T (2007) Antiphospholipid antibodies: lessons from the bench. J Autoimmun 28(2–3):129–133PubMedCrossRef Koike T, Bohgaki M, Amengual O, Atsumi T (2007) Antiphospholipid antibodies: lessons from the bench. J Autoimmun 28(2–3):129–133PubMedCrossRef
Metadaten
Titel
Systemic Lupus Erythematosus Involving the Nervous System: Presentation, Pathogenesis, and Management
verfasst von
Julia J. Rhiannon
Publikationsdatum
01.06.2008
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2008
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-007-8052-z

Weitere Artikel der Ausgabe 3/2008

Clinical Reviews in Allergy & Immunology 3/2008 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.